BioCryst Pharma (BCRX) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $8.80 +0.46%
Revenue Growth %: +3.9%
Financial Fact:
Total revenues: 7.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +3.9%
Financial Fact:
Total revenues: 7.76M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
BioCryst Pharma (NASDAQ: BCRX) reported Q1 EPS of ($0.28), $0.02 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $68.4 million versus the consensus estimate of $71.47 million.
For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Thor Industries (THO) Misses Q4 EPS by 13c
- UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
